IV Double and Triple Concentrated Nicardipine for Stroke and ICH

Recruiting

Phase 4 Results

Summary of Purpose

Hypertension (high blood pressure) can often cause neurological worsening in patients with stroke, intracerebral hemorrhage and subarachnoid hemorrhage. Intravenous infusion of nicardipine (Cardene) for control of hypertension is FDA approved. The disadvantage of Nicardipine IV drip is the relative large volume of fluid needed (up to 150 cc/hr). The purpose of this study is to evaluate safety and efficacy of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 May 2006.

1 Jan 2004 12 May 2006 Unavailable Unavailable 1 May 2006 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment

Contacts

  • David Wang, DO